Squarepoint
GSK icon

Squarepoint’s GSK GSK Stock Holding History

Squarepoint’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.1M Buy
+38,000
New +$2.06M ﹤0.01% 2144
2025
Q4 		– Sell
-8,300
Closed -$358K – 4502
2025
Q3 		$358K Sell
8,300
-52,600
-86% -$2.05M ﹤0.01% 3526
2025
Q2 		$2.34M Sell
60,900
-30,200
-33% -$1.15M ﹤0.01% 1990
2025
Q1 		$3.53M Buy
91,100
+51,800
+132% +$1.9M ﹤0.01% 1661
2024
Q4 		$1.33M Buy
39,300
+9,900
+34% +$356K ﹤0.01% 2798
2024
Q3 		$1.2M Buy
29,400
+19,600
+200% +$802K ﹤0.01% 2460
2024
Q2 		$377K Buy
+9,800
New +$412K ﹤0.01% 3281
2022
Q3 		– Sell
-7,600
Closed -$414K – 3163
2022
Q2 		$414K Buy
+7,600
New +$420K ﹤0.01% 2108

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Squarepoint's GSK Position: Q1 2026 in Review

Squarepoint reduced its GSK (GSK) stake by 18% in Q1 2026, selling an estimated $764K and leaving 62,711 shares worth $3.46M. The position accounts for ﹤0.01% of the portfolio, ranked #1775.

Squarepoint first reported a position in GSK in Q1 2019 and has held it in 24 quarters since. The position peaked at $9.28M in Q3 2022. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Squarepoint held 62,711 shares of GSK worth $3.46M as of Q1 2026.
  • Squarepoint sold 14,105 GSK shares in Q1 2026, an estimated $764K.
  • GSK made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #1775 holding.
  • Squarepoint first reported a position in GSK in Q1 2019 and has held it in 24 quarters since.
  • Squarepoint's GSK position peaked at $9.28M in Q3 2022.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.